LUCD
LUCD
NASDAQ · Health Care

Lucid Diagnostics Inc

$1.07
+0.02 (+1.90%)
As of Jun 30, 10:28 PM ET ·
Financial Highlights (FY 2026)
Revenue
9.38M
Net Income
-115,544,996
Gross Margin
-41.7%
Profit Margin
-1,232.7%
Rev Growth
+131.4%
D/E Ratio
2.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -41.7% 56.6% 56.6% 56.6%
Operating Margin -1,077.7% 10.2% 10.4% 11.2%
Profit Margin -1,232.7% 8.8% 9.2% 7.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.38M 22.63M 23.02M 23.61M
Gross Profit -3,914,977 12.81M 13.04M 13.37M
Operating Income -101,109,233 2.31M 2.39M 2.63M
Net Income -115,544,996 2.00M 2.12M 1.81M
Gross Margin -41.7% 56.6% 56.6% 56.6%
Operating Margin -1,077.7% 10.2% 10.4% 11.2%
Profit Margin -1,232.7% 8.8% 9.2% 7.7%
Rev Growth +131.4% -3.2% +10.8% -8.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 75.33M 56.69M 59.72M 60.47M
Total Equity 34.33M 97.39M 100.69M 99.13M
D/E Ratio 2.19 0.58 0.59 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -99,279,347 3.43M 3.56M 3.69M
Free Cash Flow 1.33M 1.38M 1.42M